Eligibility for Noninvasive Testing Based on the 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Stable Chest Pain: Implications From the PROMISE Trial.

Fordyce, Christopher B; Hill, C Larry; Foldyna, Borek; Douglas, Pamela S

Fordyce, Christopher B; Hill, C Larry; Foldyna, Borek; Douglas, Pamela S.

Afiliación

Fordyce CB; Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, Canada (C.B.F.).
Hill CL; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (C.L.H., P.S.D.).
Foldyna B; Cardiovascular Imaging Research Center, Massachusetts General Hospital-Harvard Medical School, Boston (B.F.).
Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (C.L.H., P.S.D.).

Circulation ; 146(7): 582-584, 2022 08 16.

Article en En | MEDLINE | ID: mdl-35969650

Asunto(s)

Cardiología; Sistema Cardiovascular; American Heart Association; Dolor en el Pecho/diagnóstico; Dolor en el Pecho/etiología; Determinación de la Elegibilidad; Humanos; Medición de Riesgo; Estados Unidos

Palabras clave

chest pain; guidelines as topic; risk assessment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cardiología / Sistema Cardiovascular Tipo de estudio: Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Circulation Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google